| 000 | 01503 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250511212142.0 | ||
| 264 | 0 | _c19910613 | |
| 008 | 199106s 0 0 eng d | ||
| 022 | _a0393-2990 | ||
| 024 | 7 |
_a10.1007/BF00221337 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSabin, A B | |
| 245 | 0 | 0 |
_aMeasles, killer of millions in developing countries: strategy for rapid elimination and continuing control. _h[electronic resource] |
| 260 |
_bEuropean journal of epidemiology _cJan 1991 |
||
| 300 |
_a1-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAerosols |
| 650 | 0 | 4 |
_aAntibodies, Viral _xbiosynthesis |
| 650 | 0 | 4 |
_aBrazil _xepidemiology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aCuba _xepidemiology |
| 650 | 0 | 4 | _aDeveloping Countries |
| 650 | 0 | 4 |
_aDominican Republic _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin M _xbiosynthesis |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aMeasles _xdiagnosis |
| 650 | 0 | 4 |
_aMeasles Vaccine _xtherapeutic use |
| 650 | 0 | 4 |
_aMeasles virus _ximmunology |
| 650 | 0 | 4 |
_aNebulizers and Vaporizers _xeconomics |
| 650 | 0 | 4 |
_aNeedles _xeconomics |
| 650 | 0 | 4 |
_aSyringes _xeconomics |
| 650 | 0 | 4 |
_aVaccination _xmethods |
| 773 | 0 |
_tEuropean journal of epidemiology _gvol. 7 _gno. 1 _gp. 1-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00221337 _zAvailable from publisher's website |
| 999 |
_c1908995 _d1908995 |
||